Dutasteride side effect profile

What side effects does Dutasteride report compared with Finasteride?

Because Dutasteride inhibits both type I and type II 5-alpha reductase, suppressing DHT more completely than Finasteride, more side effects might be expected. The comparative data do not clearly show that: a systematic review and meta-analysis found similar overall adverse-reaction rates, with no significant difference in altered libido, erectile dysfunction or ejaculation disorders.

Why does Dutasteride's half-life matter for side effects?

Finasteride clears from the body relatively quickly, while Dutasteride's elimination is far slower, so measurable levels persist for a long period after the last dose. If a side effect occurs, waiting it out therefore takes much longer, which is a legitimate reason for someone anxious about reversibility to start with Finasteride instead.

Does Dutasteride affect plans to father children?

5-alpha reductase inhibitors affect development of the male fetus, which is why blood donation is restricted while taking these drugs and for a period afterwards, and the restriction period for Dutasteride is longer, reflecting its persistence. Anyone planning to father a child should discuss this specifically with the prescriber rather than assuming.

Is Dutasteride approved for hair loss?

Finasteride 1 mg is approved for androgenetic alopecia in many countries. Dutasteride is approved for that indication in some markets but used off-label in others, being most commonly licensed for benign prostatic hyperplasia instead. Off-label use is lawful and routine but places more responsibility on the prescriber and on the patient.

Where it sits against the other options is covered under non-surgical treatment.

Sources

1. Zhou Z, et al. The efficacy and safety of Dutasteride compared with Finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis. Clinical Interventions in Aging, 2019. pubmed.ncbi.nlm.nih.gov/30863034
2. Gupta AK, Venkataraman M, Talukder M, Bamimore MA. Finasteride for hair loss: a review. Journal of Dermatological Treatment, 2022;33(4):1938-1946. pubmed.ncbi.nlm.nih.gov/34291720

This article summarises published research. It is general educational information, not medical advice, and it is not a recommendation to start, stop or change any medication. Prescription drugs carry contraindications and interactions; discuss them with a doctor who knows your medical history.